Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study

NCT06929169 is registered in ClinicalTrials.gov with Maximo Agustin Schiavone as lead sponsor.

NCT NCT06929169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06929169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study
Lead sponsor
Maximo Agustin Schiavone
Phase
Phase 2
Overall status
Recruiting
Start date
May 31, 2025
Completion date
August 31, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease requiring hemodialysis